47 results
6-K
EX-99.2
NCNA
NuCana plc
15 May 23
Current report (foreign)
4:11pm
.
Contents
Strategic report
Directors’ report
Directors’ remuneration report
Statement of directors’ responsibilities
Independent auditor’s report … locally advanced or metastatic biliary tract cancer. This decision was made following a pre-planned futility analysis by the study’s Independent Data
6-K
EX-99.2
1sb2lb2xnv4lt
2 Jun 22
Unaudited Condensed Consolidated Statements of Operations
4:05pm
6-K
EX-99.1
83189 hab2ixvayzqad
2 Mar 22
NuCana Announces Update for Phase 3 Biliary Tract Cancer Study
4:05pm
F-3
EX-1.2
w2ftli t2nip6szgzb
19 Aug 21
Shelf registration (foreign)
4:50pm
F-3
EX-4.7
w7l4plz7eqg1t
19 Aug 21
Shelf registration (foreign)
4:50pm
F-3
EX-23.1
es5wvak0 5ot7ynzv12f
19 Aug 21
Shelf registration (foreign)
4:50pm
F-3
EX-4.6
2m9nnh7 3t
19 Aug 21
Shelf registration (foreign)
4:50pm
F-3
y3htrw705 6apnu220m
19 Aug 21
Shelf registration (foreign)
4:50pm
6-K
EX-99.3
8c5c 40xdjse3l6mc
19 Aug 21
Unaudited Condensed Consolidated Statements of Operations
4:28pm
6-K
EX-1.1
1tqw9d d45z0xvuooh
18 Sep 20
NuCana Announces Pricing of a Public Offering of American Depositary Shares
4:15pm
424B5
0wjmg0o9qbn3pvo
17 Sep 20
Prospectus supplement for primary offering
4:50pm
6-K
EX-99.3
w1bevqzx2cusg mm9
16 Sep 20
NuCana Announces Proposed Public Offering of American Depositary Shares
4:23pm